Author
Year
Cohort size
Arms
type of study
Age (year)
Female (%)
≥moderate TR (%)
surgical indication: only severe
surgical indication: also less than severe with TAD or RV dysfunction or PH [8-10]
Prophylactic TR
AF (%)
EF
NYHA III-IV (%)
Follow up (year)
Roshanali44 2010 105 2 RCT 55 36% 100% YES NO NO 0,42 1
Benedetto23 2012 44 2 66 45% 25% NO YES YES 48% 0,53 70% 1
Pettinari41 2019 106 2 63 35% N/A NO YES YES 20% 0,58 3,8
Calafiore25 2009 110 2 Propensity score 65 25% 100% NO YES NO 25% 0,3 5,6
Shinn12 2016 296 2 71 43% 64% NO YES NO 59% 0,6 76% 7,4
Choi30 2018 144 2 55 62% 0% NO YES YES 82% 41% 4,3
Sohon45 2019 218 2 60 67% 44% NO YES NO 83% 0,57 54% 6,5
Carrier28 2004 463 3 Retrospective non-adjusted 60 79% 100% YES NO NO 88% 5
Dreyfus5 2005 311 2 60 39% 8% NO YES YES 29% 0,6 4,8
Ghanta32 2007 237 3 67 53% 96% NO YES NO 0,48 53% 3
Izutani35 2010 117 2 72 39% 95% NO YES NO 76% 0,57 2
Navia40 2010 2013 3 68 60% 96% NO YES NO 68% 0,47 49% 5
Calafiore26 2011 432 3 64 43% 41% NO YES NO 32% 0,47 1,8
Pfannmüller42 2012 820 2 69 54% 83% NO YES NO 61% 0,57 1,75
Ariyoshi22 2013 99 3 66 62% 100% YES NO NO 65% 4,6
Guenther33 2013 688 2 65 61% 99% NO YES NO 64% 0,55 60% 4,9
Koppers37 2013 175 2 69 57% 100% NO YES NO 0,56 1
Bertrand24 2014 78 2 68 50% 17% NO YES NO 0,52 0,39
Lin38 2014 399 3 47 53% 98% NO YES NO 41% 0,54 64% 3,3
Murashit39 2014 162 2 63 48% 61% NO YES NO 64% 0,64 38% 5,3
Chikwe29 2015 645 2 59 37% 11% NO YES NO 19% 0,61 3,7
Ren43 2015 74 2 49 85% 70% NO YES NO 0,61 96% 2,8
Gatti31 2016 527 3 70 53% NO YES NO 0,55 64% 5,2
Jouan36 2016 201 2 60 45% 17% NO YES NO 3
Wang47 2016 106 2 57 54% 100% NO YES NO 0,51 2,9
Abdelgawad20 2017 40 2 37 45% 100% YES NO NO 45% 0,53 80% 1
Ito34 2017 98 2 68 53% 42% NO YES NO 78% 43% 3,9
Verdonk46 2018 287 2 62 56% 34% NO YES NO 40% 0,08
Adas21 2019 200 3 34 59% 100% NO YES NO 48% 1,1
Calafiore27 2019 298 3 52 61% 83% NO YES NO 28% 0,48 80% 3
Zhong48 2019 170 3 53 77% 54% NO YES NO 67% 0,59 67% 1